Evidence map›Paper›PMID 12407410›Full record

ReviewNature immunology2002

Viral interference with antigen presentation.

Jonathan W Yewdell, Ann B Hill

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 259 citations in OpenAlex.

  1. Article
  2. Article
  3. Polio virotherapy provokes MDA5 signaling and CD4Microbiology and molecular biology reviews : MMBR · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Development and function of chicken XCR1Frontiers in immunology · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Infection and immunity · 2020
    Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jonathan W YewdellLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. jyewdell@nih.gov
Ann B Hill
National Institute of Allergy and Infectious Diseases · USOregon Health & Science University · US

Funding

Virus Induction Of Primary CD8 T Cell ResponsesZIAAI000814 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BENNINK, JACK R · 2009 to 2020
$6.8M
VIRUS INDUCTION OF PRIMARY CD8+ T CELL RESPONSESZ01AI000814 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI BENNINK, JACK R · 1997 to 2008
$1.7M
6 · The paper itself

Abstract

CD8+ T cells play an important role in immunity to viruses. Just how important these cells are is demonstrated by the evolution of viral strategies for blocking the generation or display of peptide-major histocompatibility complex class I complexes on the surfaces of virus-infected cells. Here, we focus on viral interference with antigen presentation; in particular we consider the importance (and difficulty) of establishing the evolutionary significance (that is, the ability to enhance viral transmission) of viral gene products that interfere with antigen presentation in vitro.

Indexed as

Antigen PresentationAnimalsAntigens, ViralCD8-Positive T-LymphocytesDendritic CellsHaplorhiniHerpesviridaeHerpesviridae InfectionsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansMiceModels, ImmunologicalSpecies SpecificityViral ProteinsVirusesAntigens, ViralHistocompatibility Antigens Class IHistocompatibility Antigens Class IIViral Proteins

Identifiers

PMID12407410
OpenAlexW2090645887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.